Epizyme Says FDA Accepts INDA for Its Tazemetostat In Mesothelioma
May 04, 2016 at 07:53 AM EDT
Epizyme, Inc. (NASDAQ: EPZM) disclosed that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.